Last Defendants Settle With Sanofi Over Eloxatin
Sanofi-Aventis SA on Tuesday announced settlements with Hospira Inc., Par Pharmaceuticals Inc. and Actavis, the three remaining defendants in patent litigation over cancer drug Eloxatin....To view the full article, register now.
Already a subscriber? Click here to view full article